GSK said on Thursday it agreed to confidentially settle one more lawsuit in California that alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements to end costly litigation.
The case was set to go to trial on Feb. 20 and instead, will now be dismissed, the British drugmaker said in
GSK said on Thursday it agreed to confidentially settle one more lawsuit in California that alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements to end costly litigation.
The case was set to go to trial on Feb. 20 and instead, will now be dismissed, the British drugmaker said in a statement.
a statement.